Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
33%
Ph phase_1
1
33%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 1Safety & dosage
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Other(1)

Detailed Status

Recruiting1
unknown1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (50.0%)
N/A1 (50.0%)

Trials by Status

recruiting133%
unknown133%
completed133%

Recent Activity

1 active trials
Showing 3 of 3
recruitingnot_applicable

Transoral Endoscopic Thyroidectomy by Vestibular Approach (TOETVA)

NCT05412680
completed

TOETVA Feasibility and Complications - Single Center First Experience

NCT05396703
unknownphase_1

The Safety and Feasibility of Transoral Endoscopic Thyroidectomy Vestibular Approach

NCT04842942

Clinical Trials (3)

Showing 3 of 3 trials
NCT05412680Not Applicable

Transoral Endoscopic Thyroidectomy by Vestibular Approach (TOETVA)

Recruiting
NCT05396703

TOETVA Feasibility and Complications - Single Center First Experience

Completed
NCT04842942Phase 1

The Safety and Feasibility of Transoral Endoscopic Thyroidectomy Vestibular Approach

Unknown

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3